Literature DB >> 15243090

Purification of Enterocytozoon bieneusi spores from stool specimens by gradient and cell sorting techniques.

Zuzana Kucerova1, Hercules Moura, Gordon J Leitch, Rama Sriram, Caryn Bern, Vivian Kawai, Daniel Vargas, Robert H Gilman, Eduardo Ticona, Aldo Vivar, Govinda S Visvesvara.   

Abstract

A three-step method for the purification of Enterocytozoon bieneusi spores from stool specimens was developed. The primary process of purification of the spores from bacterial contaminants involved Percoll gradient centrifugation followed by additional separation using cesium chloride density gradient centrifugation. The cesium chloride-isolated spores were further purified using a flow cytometer with cell sorting capabilities. Sorting was performed without the use of antibodies, fluorochromes, or dyes, leaving the sorted spores in their native state, which appears to be less destructive for spores. When quantified by flow cytometry using tubes with known numbers of highly fluorescent polystyrene beads, the sorted material showed a slight decrease in light scatter characteristics compared with the slightly larger Encephalitozoon species spores. Although the overall recovery of the E. bieneusi spores was low, calcofluor and Gram chromotrope staining, indirect immunofluorescence assay, and transmission electron microscopy revealed that the sorted material was highly purified and contained large numbers of E. bieneusi spores and relatively few bacteria and other debris. The sorted material appeared to be sufficiently pure and could be used for in vitro culture and for the development of a variety of diagnostic reagents as well as in studying the genome of E. bieneusi and host-parasite interactions.

Entities:  

Mesh:

Year:  2004        PMID: 15243090      PMCID: PMC446316          DOI: 10.1128/JCM.42.7.3256-3261.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Isolation of purified oocyst walls and sporocysts from Toxoplasma gondii.

Authors:  William V Everson; Michael W Ware; J P Dubey; H D Alan Lindquist
Journal:  J Eukaryot Microbiol       Date:  2002 Jul-Aug       Impact factor: 3.346

2.  One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Authors:  I Accoceberry; M Thellier; A Datry; I Desportes-Livage; S Biligui; M Danis; X Santarelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Staining of microsporidian spores by optical brighteners with remarks on the use of brighteners for the diagnosis of AIDS associated human microsporidioses.

Authors:  J Vávra; R Dahbiová; W S Hollister; E U Canning
Journal:  Folia Parasitol (Praha)       Date:  1993       Impact factor: 2.122

4.  Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus--negative patients from Vigo, Spain.

Authors:  Beatriz Lores; Isabel López-Miragaya; Cristina Arias; Soledad Fenoy; Julio Torres; Carmen del Aguila
Journal:  Clin Infect Dis       Date:  2002-02-25       Impact factor: 9.079

5.  Separation of a cysteine-rich surface antigen-expressing variant from a cloned Giardia isolate by fluorescence-activated cell sorting.

Authors:  T Bruderer; E Niederer; P Köhler
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

6.  Fractionation of sporogonial stages of the microsporidian Encephalitozoon cuniculi by Percoll gradients.

Authors:  L C Green; P J Didier; E S Didier
Journal:  J Eukaryot Microbiol       Date:  1999 Jul-Aug       Impact factor: 3.346

7.  Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group.

Authors:  R Weber; R T Bryan; R L Owen; C M Wilcox; L Gorelkin; G S Visvesvara
Journal:  N Engl J Med       Date:  1992-01-16       Impact factor: 91.245

8.  Comparative study of microsporidian spores by flow cytometric analysis.

Authors:  J M Amigó; M P Gracia; J Comas; H Salvadó; C P Vivarès
Journal:  J Eukaryot Microbiol       Date:  1994 May-Jun       Impact factor: 3.346

9.  Enterocytozoon bieneusi infection in an immunocompetent patient who had acute diarrhea and who was not infected with the human immunodeficiency virus.

Authors:  J Sandfort; A Hannemann; H Gelderblom; K Stark; R L Owen; B Ruf
Journal:  Clin Infect Dis       Date:  1994-09       Impact factor: 9.079

Review 10.  Human microsporidial infections.

Authors:  R Weber; R T Bryan; D A Schwartz; R L Owen
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more
  5 in total

1.  Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Authors:  Quanshun Zhang; Inderpal Singh; Abhineet Sheoran; Xiaochuan Feng; John Nunnari; Angela Carville; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Serial propagation of the microsporidian Enterocytozoon bieneusi of human origin in immunocompromised rodents.

Authors:  Xiaochuan Feng; Donna E Akiyoshi; Abhineet Sheoran; Inderpal Singh; Joel Hanawalt; Quanshun Zhang; Giovanni Widmer; Saul Tzipori
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Flow cytometry analysis of Nosema species to assess spore viability and longevity.

Authors:  J G Sánchez Collado; M Higes; L Barrio; R Martín-Hernández
Journal:  Parasitol Res       Date:  2014-02-20       Impact factor: 2.289

4.  Production and characterization of monoclonal antibodies against Encephalitozoon intestinalis and Encephalitozoon sp. spores and their developmental stages.

Authors:  Fernando Izquierdo; Hercules Moura; Fernando Jorge Bornay-Llinares; Rama Sriram; Carolina Hurtado; Ángela Magnet; Soledad Fenoy; Govinda Visvesvara; Carmen Del Aguila
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

5.  Seropositivity for Enterocytozoon bieneusi, Czech Republic.

Authors:  Bohumil Sak; Zuzana Kucerova; Martin Kvac; Dana Kvetonova; Michael Rost; Evan W Secor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.